REVIEW – PERKEMBANGAN VIRUS ZIKA

Authors

  • Rizky Ramadhan Maulana
  • Irma Antasionasti
  • Fatimawali Fatimwali
  • Trina Tallei

DOI:

https://doi.org/10.35799/pha.11.2022.41742

Abstract

ABSTRACT

Zika virus (ZIKV) is a virus of the genus Flavivirus (family Flaviviridae) that is capable of infecting humans. This virus poses a risk to human health. The main vector for the spread of ZIKV is the bite of the Aedes aegypti and Aedes albopictus mosquitoes. To date, there is no approved specific treatment for ZIKV infection, the recommended therapy is supportive to treat symptoms. Vaccine development continues to be carried out as a concrete step to overcome the global spread of the virus. This article discusses the genome structure, epidemiology, viral transmission, clinical manifestations, vaccine development, and prevention and treatment of ZIKV infection.

 

Keywords: Zika Virus, Epidemiology, Transmission, Vaccines.

 

ABSTRAK

Virus Zika (ZIKV) merupakan virus dari genus Flavivirus (famili Flaviviridae) yang mampu menginfeksi manusia. Virus Zika dapat menjadi ancaman bagi kesehatan manusia.Vektor utama penyebaran ZIKV adalah gigitan nyamuk Aedes aegypti dan Aedes albopictus. Sampai saat ini, belum ada pengobatan spesifik yang disetujui untuk infeksi ZIKV, terapi yang dianjurkan bersifat suportif untuk mengobati gejala.Pengembangan vaksin terus dilakukan sebagai langkah kongkrit untuk mengatasi penyebaran virussecara global.Artikel ini membahas mengenai struktur genom, epidemiologi, transmisi virus, manifestasi klinis, pengembangan vaksin serta pencegahan dan pengobatan dari infeksi ZIKV.

 

Kata Kunci: Virus Zika, Epidemiologi, Transmisi, Vaksin

Downloads

Published

2022-07-02

How to Cite

Maulana, R. R., Antasionasti, I., Fatimwali, F., & Tallei, T. (2022). REVIEW – PERKEMBANGAN VIRUS ZIKA. PHARMACON, 11(2), 1495–1502. https://doi.org/10.35799/pha.11.2022.41742

Issue

Vol. 11 No. 2 (2022): PHARMACON

Section

Articles

License

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a  Creative Commons Attribution-NonCommercial 4.0 International License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

  2. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)